Sign In
Buy HSDT
$1.51
-0.120 (-7.36%)
At Close: Jun 23, 2026
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
06:30am, Monday, 29'th Mar 2021
First and only tongue-delivered neuromodulation therapy provides new treatment option for U.S. patients living with gait deficit due to symptoms from multiple sclerosis First and only tongue-delivered
Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd
04:05pm, Wednesday, 17'th Mar 2021
NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors
07:05am, Wednesday, 17'th Mar 2021
NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript
08:52pm, Wednesday, 10'th Mar 2021
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q4 2020 Results - Earnings Call Transcript
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
04:05pm, Wednesday, 10'th Mar 2021
NEWTOWN, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
HSDT Stock Price Increases Over 14% Pre-Market: Why It Happened
08:31am, Friday, 12'th Feb 2021
The stock price of Helius Medical Technologies Inc (NASDAQ: HSDT) is trading at over 14% pre-market. This is why it happened.
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
07:30am, Tuesday, 02'nd Feb 2021
NEWTOWN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
NEWTOWN, Pa., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ann
NEWTOWN, Pa., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards
07:05am, Tuesday, 19'th Jan 2021
The Company's Stock Will Continue to be Listed and Traded on The Nasdaq Stock Market
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference
12:37pm, Friday, 15'th Jan 2021
NEWTOWN, Pa., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Submits formal response to the U.S. Food and Drug Administration's request for additional information Submits formal response to the U.S. Food and Drug Administration's request for additional informat
Helius Medical Technologies, Inc. Comments on Unusual Market Activity
04:05pm, Tuesday, 05'th Jan 2021
NEWTOWN, Pa., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, is
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January
07:05am, Monday, 04'th Jan 2021
NEWTOWN, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. Announces Reverse Stock Split
07:05am, Thursday, 31'st Dec 2020
NEWTOWN, Pa., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, ann
